Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920075 · ClinicalTrials.gov registry record
Alendronate in Juvenile Osteoporosis
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 11
- Enrollment target
NCT00920075: Completed study, sponsored by Medical University of South Carolina.
NCT00920075 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00920075 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The investigators earlier have shown that treatment of patients with juvenile osteoporosis with alendronate (Fosamax) for 12 months increased the bone density without side effects. In an open label study (10 patients) and double blind, crossover study (11 patients alendronate and 11 patients placebo), the investigators have further observed that alendronate increased the bone density significantly where as placebo (calcium and vitamin D) increased only minimally. These trials were completed. Thus, a post study is designed to evaluate the current status of the bone density and fractures after the patients discontinued the alendronate treatment. No treatment is involved.
Primary Outcome
Participants who earlier completed in our open labeled or double blind study of alendronate treatment for juvenile osteoporosis, were invited for one clinical visit. Bone density of spine was measured by DXA scan.
Interventions
- DRUG Alendronate (Fosamax)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-10 |
What the finished NCT00920075 record still lists
NCT00920075 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Alendronate (Fosamax) is the first listed.
NCT00920075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00920075 about?
NCT00920075 is a clinical study titled "Alendronate in Juvenile Osteoporosis". The investigators earlier have shown that treatment of patients with juvenile osteoporosis with alendronate (Fosamax) for 12 months increased the bone density without side effects. In an open label study (10 patients) and double blind, crossover study (11 patients alendronate and 11 patients placebo...
What is the current status of trial NCT00920075?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2009-07. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00920075?
The interventions under investigation include: Alendronate (Fosamax) (DRUG).
Who is sponsoring clinical trial NCT00920075?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia